Evidence map›Paper›PMID 26918916›Full record

ArticleCell cycle (Georgetown, Tex.)2016

APOBEC3A damages the cellular genome during DNA replication.

Abby M Green, Sébastien Landry, Konstantin Budagyan, Daphne C Avgousti, Sophia Shalhout, Ashok S Bhagwat, Matthew D Weitzman

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 95 citations in OpenAlex.

  1. Distinct repair processes produce APOBEC-induced deletions, tandem substitutions, and complex mutations in yeast and human cells.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. STING causes replication stress and nascent DNA degradation via SAMHD1.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Abby M Greena Division of Oncology , Department of Pediatrics , Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine , Philadelphia , PA , USA.
Sébastien Landryc Faculty of Pharmacy, Université de Montréal , Montréal , QC , Canada.
Konstantin Budagyand Division of Cancer Pathobiology , Department of Pathology and Laboratory Medicine , Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine , Philadelphia , PA , USA.
Daphne C Avgoustid Division of Cancer Pathobiology , Department of Pathology and Laboratory Medicine , Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine , Philadelphia , PA , USA.
Sophia Shalhoute Department of Chemistry , Wayne State University , Detroit , MI , USA.
Ashok S Bhagwate Department of Chemistry , Wayne State University , Detroit , MI , USA.
Matthew D Weitzmanb Center for Childhood Cancer Research, Children's Hospital of Philadelphia , Philadelphia , PA , USA.
Children's Hospital of Philadelphia · USWayne State University · USUniversité de Montréal · CA

Funding

Physician Scientist Training in Clinical OncologyK12CA076931 · NCI · UNIVERSITY OF PENNSYLVANIA · PI STEPHEN Patrick HUNGER, LYNN M. SCHUCHTER · 1997 to 2026
$16.5M
Training In Tumor VirologyT32CA115299 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2006 to 2021
$4.7M
TRANSCRIPTION--INDUCED MUTATIONSR01GM057200 · NIGMS · WAYNE STATE UNIVERSITY · PI BHAGWAT, ASHOK S · 1998 to 2014
$2.6M
The human APOBEC3A deaminase - genomic instability and regulationR01CA181359 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI WEITZMAN, MATTHEW D. · 2014 to 2018
$1.7M
Exploring the oncogenic potential of human APOBEC3 cytosine deaminasesR21CA185799 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI WEITZMAN, MATTHEW D. · 2015 to 2016
$402k
Investigating chromatin control by an Adenovirus histone-like proteinF32GM112414 · NIGMS · CHILDREN'S HOSP OF PHILADELPHIA · PI AVGOUSTI, DAPHNE CHRISTINA · 2015 to 2015
$54k
NCI NIH HHS CA181259NCI NIH HHS CA185799NCI NIH HHS K12 CA076931NCI NIH HHS R01 CA181359NCI NIH HHS R21 CA185799NCI NIH HHS T32 CA115299NIGMS NIH HHS F32 GM112414NIGMS NIH HHS GM57200NIGMS NIH HHS R01 GM057200
6 · The paper itself

Abstract

The human APOBEC3 family of DNA-cytosine deaminases comprises 7 members (A3A-A3H) that act on single-stranded DNA (ssDNA). The APOBEC3 proteins function within the innate immune system by mutating DNA of viral genomes and retroelements to restrict infection and retrotransposition. Recent evidence suggests that APOBEC3 enzymes can also cause damage to the cellular genome. Mutational patterns consistent with APOBEC3 activity have been identified by bioinformatic analysis of tumor genome sequences. These mutational signatures include clusters of base substitutions that are proposed to occur due to APOBEC3 deamination. It has been suggested that transiently exposed ssDNA segments provide substrate for APOBEC3 deamination leading to mutation signatures within the genome. However, the mechanisms that produce single-stranded substrates for APOBEC3 deamination in mammalian cells have not been demonstrated. We investigated ssDNA at replication forks as a substrate for APOBEC3 deamination. We found that APOBEC3A (A3A) expression leads to DNA damage in replicating cells but this is reduced in quiescent cells. Upon A3A expression, cycling cells activate the DNA replication checkpoint and undergo cell cycle arrest. Additionally, we find that replication stress leaves cells vulnerable to A3A-induced DNA damage. We propose a model to explain A3A-induced damage to the cellular genome in which cytosine deamination at replication forks and other ssDNA substrates results in mutations and DNA breaks. This model highlights the risk of mutagenesis by A3A expression in replicating progenitor cells, and supports the emerging hypothesis that APOBEC3 enzymes contribute to genome instability in human tumors.

Indexed as

DNA DamageDNA ReplicationCell Cycle CheckpointsCell LineCytidine DeaminaseDeaminationGenomeHumansProteinsStress, PhysiologicalAPOBEC3A protein, humanCytidine DeaminaseProteinsAPOBEC3ATR kinasecell cycle checkpointcytosine deaminationDNA replicationDNA replication stresssingle-stranded DNA

Identifiers

PMID26918916
PMCPMC4889253
OpenAlexW2289874636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.